pharmaceuticals

Gilead Sciences, Inc. (NASDAQ: GILD) reported total revenue of $6.6 billion for the second quarter of 2023, which was up…

Key highlights from Cigna Corporation (CI) Q2 2023 Earnings Concall Q&A Highlights: [00:21:37] Scott Fidel with Stephens asked how are…

Healthcare firm Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported an increase in adjusted earnings and revenues for the second…

Key highlights from Moderna, Inc (MRNA) Q2 2023 Earnings Concall Management Update: [00:16:30] MRNA’s COVID sales expectations for 2023 are…

Healthcare company The Cigna Group (NYSE: CI) on Thursday reported a 7% increase in revenues for the second quarter of…

Moderna, Inc. (NASDAQ: MRNA) reported second quarter 2023 earnings results today. Total revenue dropped to $344 million from $4.7 billion…

McKesson Corporation (NYSE: MCK), a diversified healthcare service company that operates in partnership with biopharma companies, care providers, pharmacies, and…

Key highlights from CVS Health Corporation (CVS) Q2 2023 Earnings Concall Management Update: [00:14:22] CVS said its restructuring efforts are…

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported product revenue of $2.49 billion for the second quarter of 2023, which was up 14%…

Healthcare conglomerate CVS Health Corporation (NYSE: CVS) announced second-quarter 2023 results, reporting lower earnings despite an increase in revenues. June…

AmerisourceBergen Corporation (NYSE: ABC) reported third quarter 2023 earnings results today. Revenue increased 11.5% year-over-year to $66.9 billion. Net income…

Shares of Pfizer Inc. (NYSE: PFE) were down over 1% on Tuesday after the company delivered mixed results for the…

Key highlights from Merck & Co., Inc. (MRK) Q2 2023 Earnings Concall Management Update: [00:18:54] MRK said it will continue…

Merck (NYSE: MRK) reported second quarter 2023 earnings results today. Total worldwide sales were $15 billion, up 3% from the…

Pfizer Inc. (NYSE: PFE) reported second quarter 2023 earnings results today. Revenues decreased 54% year-over-year to $12.7 billion. Reported net…

Healthcare company DexCom, Inc. (NASDAQ: DXCM) reported a double-digit increase in second-quarter earnings and also provided full-year guidance. Second-quarter revenue…

Medical device maker Boston Scientific Corporation (NYSE: BSX) reported financial results for the second quarter of 2023. The company also provided…

Biotechnology company Bristol Myers Squibb (NYSE: BMY) on Thursday said its second-quarter adjusted earnings decreased year-over-year, hurt by a fall…

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower earnings, on an adjusted basis, and revenues for the second quarter of…

Health insurance company UnitedHealth Group (NYSE: UNH) reported strong second-quarter results last week, triggering a stock rally. The company also…

Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) entered a new phase recently after spinning off its consumer business. The move…